The government’s Medicines and Healthcare products Regulatory Agency (MHRA) has found that Cannabidiol (CBD) has a “restoring, correcting or modifying” effect on “physiological functions” when administered to humans, in a potential milestone in the campaign to legalise cannabis and bring about evidence-based laws regarding drugs.
The review of CBD, a cannabinoid accounting for up to 40% of the marijuana plant’s extract that doesn’t contain its psychoactive THC but is purported to retain the health benefits, came about following discussions with CBD vaporiser company MediPen.
The MHRA’s findings are not directly applicable to the government’s response to last year’s petition to legalise cannabis, but stand in stark contrast, with the petition having been batted away by the Home Office with the assessment that cannabis “can unquestionably cause harm to individuals and society”. [Read more at Independent]
Your email address will not be published. Required fields are marked *
Name *
Email *
Website
Save my name, email, and website in this browser for the next time I comment.
Comment *
Notify me of follow-up comments by email.
Notify me of new posts by email.
Δ
Saturday marks marijuana culture’s high holiday, 4/20, when college students gather — at 4:20 p.m. — in clouds of smoke on campus quads and pot shops in legal-weed states thank…
The state budget that’s expected to be adopted in the coming days calls for repealing the potency tax on marijuana products as well as new regulations intended to give local municipalities, including…
SEATTLE (AP) — Saturday marks marijuana culture’s high holiday, 4/20, when college students gather — at 4:20 p.m. — in clouds of smoke on campus quads and pot shops in…
Significant adjustments have been made to Connecticut House Bill No. 5150, the omnibus cannabis/hemp legislation that is waiting to be taken up by the full House. An amended version of…